Related Experiment Videos
Phenytoin and IgA concentrations in plasma and saliva in epileptic children
Acta Paediatrica Scandinavica
|January 1, 1981
Insights
This study found that phenytoin levels in children with epilepsy remained stable during dosage intervals. Saliva immunoglobulin A (IgA) levels in these children were comparable to those without epilepsy.
Area of Science:
- Pharmacology
- Immunology
- Pediatrics
Background:
- Epilepsy management often involves long-term anticonvulsant therapy.
- Phenytoin is a commonly prescribed antiepileptic drug.
- Monitoring drug concentrations and potential immune effects is crucial in pediatric patients.
Purpose of the Study:
- To investigate the correlation between plasma and saliva phenytoin concentrations.
- To assess the variation of phenytoin and immunoglobulin A (IgA) levels during dosage intervals in epileptic children.
- To compare salivary IgA concentrations in phenytoin-treated children with controls.
Main Methods:
- Measurement of phenytoin and IgA concentrations in plasma and saliva.
- Analysis of 36 epileptic children with a mean age of 11 years.
- Comparison of phenytoin-treated children with a control group.
Main Results:
- A strong positive correlation (r = 0.94) was observed between plasma and saliva phenytoin concentrations.
- Phenytoin and IgA concentrations exhibited minimal fluctuation within the dosage interval.
- No significant difference in salivary IgA levels was found between phenytoin-treated children and controls.
Conclusions:
- Saliva can serve as a reliable non-invasive matrix for monitoring phenytoin concentrations in pediatric epilepsy.
- Phenytoin therapy does not appear to significantly alter salivary IgA levels in children.
- Stable drug concentrations and normal IgA levels suggest good therapeutic management and no immediate immunomodulatory concerns.
Abstract:
The concentrations of immunoglobulin A (IgA) and phenytoin were determined in 36 epileptic children with a mean age of 11 years. There was a good correlation between the plasma and saliva concentrations of phenytoin (r = 0.94). The concentration of phenytoin and IgA showed little variation during the dosage interval. The phenytoin treated children did not differ with respect to the concentrations of IgA in saliva in comparison to the controls.